Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Screening-based approaches to identify small molecules that inhibit protein–protein interactions
Sehee Choi, Kang‐Yell Choi
Expert Opinion on Drug Discovery (2017) Vol. 12, Iss. 3, pp. 293-303
Closed Access | Times Cited: 24

Showing 24 citing articles:

Next generation antibody drugs: pursuit of the 'high-hanging fruit'
Paul J. Carter, Greg A. Lazar
Nature Reviews Drug Discovery (2017) Vol. 17, Iss. 3, pp. 197-223
Closed Access | Times Cited: 671
High-Throughput Screening: today’s biochemical and cell-based approaches
Vincent Blay, Bhairavi Tolani, Sunita P. Ho, et al.
Drug Discovery Today (2020) Vol. 25, Iss. 10, pp. 1807-1821
Closed Access | Times Cited: 237
Creating and screening natural product libraries
Brice A. P. Wilson, Christopher C. Thornburg, Curtis J. Henrich, et al.
Natural Product Reports (2020) Vol. 37, Iss. 7, pp. 893-918
Open Access | Times Cited: 117
The design and development of covalent protein-protein interaction inhibitors for cancer treatment
Shasha Cheng, Guan‐Jun Yang, Wanhe Wang, et al.
Journal of Hematology & Oncology (2020) Vol. 13, Iss. 1
Open Access | Times Cited: 82
New insights into protein–protein interaction modulators in drug discovery and therapeutic advance
Hossam Nada, Yongseok Choi, Sung-Do Kim, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 16
Cytosolic Protein Delivery for Intracellular Antigen Targeting Using Supercharged Polypeptide Delivery Platform
Qun Wang, Yifan Yang, Dingkang Liu, et al.
Nano Letters (2021) Vol. 21, Iss. 14, pp. 6022-6030
Closed Access | Times Cited: 36
Constrained Peptides in Drug Discovery and Development
Douglas R. Cary, Masaki Ohuchi, Patrick Reid, et al.
Journal of Synthetic Organic Chemistry Japan (2017) Vol. 75, Iss. 11, pp. 1171-1178
Open Access | Times Cited: 42
Methods for Discovering and Targeting Druggable Protein-Protein Interfaces and Their Application to Repurposing
E. Sıla Özdemir, Farideh Halakou, Ruth Nussinov, et al.
Methods in molecular biology (2018), pp. 1-21
Open Access | Times Cited: 33
Abrogating the Interaction Between p53 and Mortalin (Grp75/HSPA9/mtHsp70) for Cancer Therapy: The Story so far
Ahmed Elwakeel
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 19
An Overview of Computational Methods, Tools, Servers, and Databases for Drug Repurposing
Sailu Sarvagalla, Safiulla Basha Syed, Mohane Selvaraj Coumar
Elsevier eBooks (2019), pp. 743-780
Closed Access | Times Cited: 24
Implications of the Essential Role of Small Molecule Ligand Binding Pockets in Protein–Protein Interactions
Jeffrey Skolnick, Hongyi Zhou
The Journal of Physical Chemistry B (2022) Vol. 126, Iss. 36, pp. 6853-6867
Open Access | Times Cited: 14
Identifying promising druggable binding sites and their flexibility to target the receptor-binding domain of SARS-CoV-2 spike protein
Mariem Ghoula, Sarah Naceri, S. Sitruk, et al.
Computational and Structural Biotechnology Journal (2023) Vol. 21, pp. 2339-2351
Open Access | Times Cited: 7
Partial filling affinity capillary electrophoresis as a useful tool for fragment-based drug discovery: A proof of concept on thrombin
Elena Farcaş, Charlotte Bouckaert, Anne‐Catherine Servais, et al.
Analytica Chimica Acta (2017) Vol. 984, pp. 211-222
Closed Access | Times Cited: 21
Targeting Neph1 and ZO-1 protein-protein interaction in podocytes prevents podocyte injury and preserves glomerular filtration function
Amin Sagar, Ehtesham Arif, Ashish K. Solanki, et al.
Scientific Reports (2017) Vol. 7, Iss. 1
Open Access | Times Cited: 21
Enhanced Thermal Stability and Reduced Aggregation in an Antibody Fab Fragment at Elevated Concentrations
Cheng Zhang, Jordan W. Bye, Lok Hin Lui, et al.
Molecular Pharmaceutics (2023) Vol. 20, Iss. 5, pp. 2650-2661
Open Access | Times Cited: 6
Drug Repositioning Using Computer-aided Drug Design (CADD)
S. Rawat, Kanmani Subramaniam, Selva Kumar Subramanian, et al.
Current Pharmaceutical Biotechnology (2023) Vol. 25, Iss. 3, pp. 301-312
Closed Access | Times Cited: 6
Ultra-high-throughput Ca2+ assay in platelets to distinguish ITAM-linked and G-protein-coupled receptor activation
Delia I. Fernández, Isabella Provenzale, Hilaire Yam Fung Cheung, et al.
iScience (2021) Vol. 25, Iss. 1, pp. 103718-103718
Open Access | Times Cited: 13
Medicinal Chemistry Strategies for the Development of Inhibitors Disrupting β-Catenin’s Interactions with Its Nuclear Partners
Hao Zhang, Chenglong Liu, Di Zhu, et al.
Journal of Medicinal Chemistry (2022) Vol. 66, Iss. 1, pp. 1-31
Closed Access | Times Cited: 10
Assessing Interactions between Helical Aromatic Oligoamide Foldamers and Protein Surfaces: A Tethering Approach
Maëlle Vallade, Michał Jewgiński, Lucile Fischer, et al.
Bioconjugate Chemistry (2018) Vol. 30, Iss. 1, pp. 54-62
Open Access | Times Cited: 13
Extraction of molecular features for the drug discovery targeting protein‐protein interaction of Helicobacter pylori CagA and tumor suppressor protein ASSP2
Muhammad Junaid, Cheng‐Dong Li, Masaud Shah, et al.
Proteins Structure Function and Bioinformatics (2019) Vol. 87, Iss. 10, pp. 837-849
Closed Access | Times Cited: 12
Indirubin-3′-alkoxime derivatives for upregulation of Wnt signaling through dual inhibition of GSK-3β and the CXXC5-Dvl interaction
Doona Song, Yunja Lee, Min‐Jeong Kang, et al.
Bioorganic Chemistry (2022) Vol. 121, pp. 105664-105664
Closed Access | Times Cited: 3
Small-Molecule Inhibitors of Protein–Protein Interactions as Therapeutics
Krishna Mohan Poluri, Khushboo Gulati, Deepak Kumar Tripathi, et al.
(2023), pp. 343-428
Closed Access | Times Cited: 1
Experimental Methods Used for Identifying Small-Molecule Inhibitors of Protein-Protein Interaction
Mi Zhou, Qing Li, Wenna Kong, et al.
Springer eBooks (2018), pp. 95-133
Closed Access | Times Cited: 2
High-Throughput Screening in the Discovery of Small-Molecule Inhibitors of Protein-Protein Interactions
Chunlin Zhuang, Chunquan Sheng
Springer eBooks (2018), pp. 29-51
Closed Access | Times Cited: 2
Page 1

Scroll to top